in accordance with § 5 of the German Telemedia Act (TMG):
T + 49 89 864667 100
F + 49 89 864667 110
Dr. Stefan Glombitza, Nicola Mikulcik, Dr. Andreas Seidl
Dr. Olaf Stiller (Chairman), Peter Wendeln (Deputy Chairman),
Klaus Röhrig, Dr. Thomas Strüngmann
District Court of Munich HRB 200801
according to § 27 a sales tax law:
in accordance with § 55 Para. 2 of the German Interstate Treaty on Broadcasting (Rundfunkstaatsvertrag – RStV)
Dr. Nicolas Combé
This website may contain forward-looking statements and information which are based on our current expectations and certain assumptions. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, performance of the company, development of the products and the estimates given here.
Such known and unknown risks and uncertainties comprise, among others, the research and development, the regulatory approval process, the timing of the actions of regulatory bodies and other governmental authorities, clinical results, changes in laws and regulations, product quality, patient safety, patent litigation, contractual risks and dependencies from third parties. With respect to pipeline products, Formycon AG does not provide any representation, warranties or any other guarantees that the products will receive the necessary regulatory approvals or that they will prove to be commercially exploitable and/or successful.
Formycon AG assumes no obligation to update these forward-looking statements or to correct them in case of developments which differ from those anticipated.
This website neither constitutes an offer to sell nor a solicitation of an offer to buy or subscribe for securities of Formycon AG. No public offering of securities of Formycon AG will be made nor is a public offering intended.
This website and the information contained therein may not be distributed in or into the United States of America, Canada, Australia, Japan or any other jurisdictions, in which such offer or such solicitation would be prohibited. This document does not constitute an offer for the sale of securities in the United States.
Concept & Realisation: